Group 1 - The legal opinion letter is issued by Zhejiang Tiance Law Firm regarding the differentiated equity distribution plan of Zhejiang Jiuzhou Pharmaceutical Co., Ltd for the first half of 2025 [1][2] - The company plans to distribute a cash dividend of 2.00 yuan (including tax) for every 10 shares to all shareholders [4][5] - The total share capital of the company is 889,446,028 shares, with 7,736,000 shares held in the repurchase special securities account, which will not participate in the profit distribution [4][5] Group 2 - The actual number of shares participating in the dividend distribution is calculated by deducting the shares in the repurchase account from the total share capital, resulting in a total of 881,710,028 shares eligible for the cash dividend [5][7] - The total cash dividend to be distributed amounts to 176,342,005.60 yuan (including tax) [5] - The ex-dividend reference price is calculated based on the closing price before the dividend distribution, which is 18.58 yuan per share, leading to an adjusted reference price of 18.38 yuan per share after accounting for the cash dividend [6][7] Group 3 - The legal opinion concludes that the differentiated equity distribution complies with relevant laws and regulations, including the Company Law and Securities Law, and does not harm the interests of the company or its shareholders [5][7]
九洲药业: 浙江天册律师事务所关于浙江九洲药业股份有限公司2025年半年度差异化权益分派事项的法律意见书